Gadducci A - Search Results

1

Evolving role of serum biomarkers in the management of ovarian cancer.

Gadducci A, Cosio S, Zanca G, Genazzani AR. Gadducci A, et al. Womens Health (Lond). 2006 Jan;2(1):141-58. doi: 10.2217/17455057.2.1.141. Womens Health (Lond). 2006. PMID: 19803934 Free article.

2

Renal impairment in patients with ovarian cancer.

Donadio C, Lucchesi A, Ardini M, Cosio S, Gadducci A. Donadio C, et al. Among authors: gadducci a. Eur J Obstet Gynecol Reprod Biol. 2003 Feb 10;106(2):198-202. doi: 10.1016/s0301-2115(02)00234-8. Eur J Obstet Gynecol Reprod Biol. 2003. PMID: 12551792

3

Human telomerase reverse transcriptase mRNA expression assessed by real-time reverse transcription polymerase chain reaction predicts chemosensitivity in patients with ovarian carcinoma.

Buttitta F, Pellegrini C, Marchetti A, Gadducci A, Cosio S, Felicioni L, Barassi F, Salvatore S, Martella C, Coggi G, Bosari S. Buttitta F, et al. Among authors: gadducci a. J Clin Oncol. 2003 Apr 1;21(7):1320-5. doi: 10.1200/JCO.2003.09.065. J Clin Oncol. 2003. PMID: 12663721

4

Intratumoral microvessel density, response to chemotherapy and clinical outcome of patients with advanced ovarian carcinoma.

Gadducci A, Viacava P, Cosio S, Fanelli G, Fanucchi A, Cecchetti D, Cristofani R, Genazzani AR. Gadducci A, et al. Anticancer Res. 2003 Jan-Feb;23(1B):549-56. Anticancer Res. 2003. PMID: 12680144

5

The management of malignant nondysgerminomatous ovarian germ cell tumors.

Gadducci A, Cosio S, Muraca S, Genazzani AR. Gadducci A, et al. Anticancer Res. 2003 Mar-Apr;23(2C):1827-36. Anticancer Res. 2003. PMID: 12820465 Review.

6

Vascular endothelial growth factor (VEGF) expression in primary tumors and peritoneal metastases from patients with advanced ovarian carcinoma.

Gadducci A, Viacava P, Cosio S, Cecchetti D, Fanelli G, Fanucchi A, Teti G, Genazzani AR. Gadducci A, et al. Anticancer Res. 2003 May-Jun;23(3C):3001-8. Anticancer Res. 2003. PMID: 12926153

7

Serum tumor markers in the management of ovarian, endometrial and cervical cancer.

Gadducci A, Cosio S, Carpi A, Nicolini A, Genazzani AR. Gadducci A, et al. Biomed Pharmacother. 2004 Jan;58(1):24-38. doi: 10.1016/j.biopha.2003.11.003. Biomed Pharmacother. 2004. PMID: 14739059 Review.

8

Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: case report and review of the literature.

Gadducci A, Cosio S, Fanucchi A, Nardini V, Roncella M, Conte PF, Genazzani AR. Gadducci A, et al. Anticancer Res. 2003 Nov-Dec;23(6D):5225-9. Anticancer Res. 2003. PMID: 14981994 Review.

9

The predictive and prognostic value of serum CA 125 half-life during paclitaxel/platinum-based chemotherapy in patients with advanced ovarian carcinoma.

Gadducci A, Cosio S, Fanucchi A, Negri S, Cristofani R, Genazzani AR. Gadducci A, et al. Gynecol Oncol. 2004 Apr;93(1):131-6. doi: 10.1016/j.ygyno.2003.12.043. Gynecol Oncol. 2004. PMID: 15047226

10

Use of estrogen antagonists and aromatase inhibitors in breast cancer and hormonally sensitive tumors of the uterine body.

Gadducci A, Cosio S, Genazzani AR. Gadducci A, et al. Curr Opin Investig Drugs. 2004 Oct;5(10):1031-44. Curr Opin Investig Drugs. 2004. PMID: 15535424 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

378 results

Search Page